Abstract: A dock bumper for minimizing damage to a back of a vehicle upon contacting a low-lying object may include a generally-rigid shock-absorbing member to be secured adjacent to a back portion of the vehicle. The shock-absorbing member may include a distal surface extended away from the back portion of the vehicle to contact a surface of a loading dock as the vehicle is operated in reverse, and a proximate surface positioned to contact a structural member at the back portion of the vehicle. A modular step may be coupled to the shock-absorbing member to dissipate at least a suitable portion of a force exerted on the step to minimize damage to the structural member contacting the proximate surface of the shock-absorbing member.

Abstract: A wireless control system can be used to selectively adjust the position of a liftgate platform with respect to a vehicle cargo hold. The wireless control system includes a transmitter for use in transmitting a wireless control signal, a receiver that receives the wireless control signal transmitted by the transmitter and communicates a corresponding control signal to an actuation device to adjust the platform and, a transmitter detection system that prevents the actuation device from operating unless the transmitter is positioned in a predetermined location.

Abstract: A wireless control system can be used to selectively adjust the position of a liftgate platform with respect to a vehicle cargo hold. The wireless control system includes a transmitter for use in transmitting a wireless control signal, a receiver that receives the wireless control signal transmitted by the transmitter and communicates a corresponding control signal to an actuation device to adjust the platform and, a transmitter detection system that prevents the actuation device from operating unless the transmitter is positioned in a predetermined location.

Abstract: A liftgate may be aligned to a vehicle by: (a) attaching at least one guide member having an aligmnent member with a contact surface to the liftgate; (b) adjusting the alignment member into a first open position; (c) positioning the liftgate at least partially under the vehicle to a position adjacent to the vehicle; (d) adjusting the alignment member into a second closed position; (e) positioning the liftgate such that the contact surface contacts the vehicle; (f) attaching the liftgate to the vehicle; and, (g) removing the guide member from the liftgate.

Abstract: A dock bumper for minimizing damage to a back of a vehicle upon contacting a low-lying object may include a generally-rigid shock-absorbing member to be secured adjacent to a back portion of the vehicle. The shock-absorbing member may include a distal surface extended away from the back portion of the vehicle to contact a surface of a loading dock as the vehicle is operated in reverse, and a proximate surface positioned to contact a structural member at the back portion of the vehicle. A modular step may be coupled to the shock-absorbing member to dissipate at least a suitable portion of a force exerted on the step to minimize damage to the structural member contacting the proximate surface of the shock-absorbing member.

Abstract: Antibodies that bind to a 40 kDa protein which is expressed on tumors, but is not expressed on normal adult hemopoietic cells are disclosed. Also disclosed are methods for production and the use of such antibodies.

Abstract: A cable for conducting electric current from a source receptacle to a load receptacle. The cable includes a primary cord including an electrical conductor with a first terminal end and a second terminal end, and a ground cord including an electrical conductor for establishing an electrical connection between a circuit including the cable and ground. A first plug is adapted to conduct the electric current between a contact provided to the source receptacle and the first terminal end, and a second plug is adapted to conduct the electric current between the second terminal end and a contact provided to the load receptacle. At least one of the first plug and the second plug is compatible with a single-prong receptacle.

Abstract: Antibodies that bind to a 40 kDa protein which is expressed on tumors, but is not expressed on normal adult hemopoietic cells are disclosed. Also disclosed are methods for production and the use of such antibodies.

Abstract: Compositions and methods for the treatment of cancer, particularly melanoma, myeloma, small cell lung cancer, thymic lymphoma, T-cell lymphoma, B-cell lymphoma, osteosarcoma, and acute T-cell leukemia, are disclosed. Illustrative compositions include one or more anti-ganglioside antibodies and polynucleotides that encode such anti-ganglioside antibodies. These antibodies may be for example, hamster antibodies, chimeric human/hamster antibodies, or humanized antibodies. The disclosed compositions are useful, for example, in the treatment of cancer and can be used to induce apoptosis in a cancer cell.

Abstract: Compositions and methods for the treatment of cancer, particularly melanoma, myeloma, small cell lung cancer, thymic lymphoma, T-cell lymphoma, B-cell lymphoma, osteosarcoma, and acute T-cell leukemia, are disclosed. Illustrative compositions include one or more anti-ganglioside antibodies and polynucleotides that encode such anti-ganglioside antibodies. These antibodies may be for example, hamster antibodies, chimeric human/hamster antibodies, or humanized antibodies. The disclosed compositions are useful, for example, in the treatment of cancer and can be used to induce apoptosis in a cancer cell.

Abstract: Compositions and methods for the treatment of cancer, particularly melanoma, myeloma, small cell lung cancer, thymic lymphoma, T-cell lymphoma, B-cell lymphoma, osteosarcoma, and acute T-cell leukemia, are disclosed. Illustrative compositions include one or more anti-ganglioside antibodies and polynucleotides that encode such anti-ganglioside antibodies. These antibodies may be for example, hamster antibodies, chimeric human/hamster antibodies, or humanized antibodies. The disclosed compositions are useful, for example, in the treatment of cancer and can be used to induce apoptosis in a cancer cell.

Abstract: A cable for conducting electric current from a source receptacle to a load receptacle. The cable includes a primary cord including an electrical conductor with a first terminal end and a second terminal end, and a ground cord including an electrical conductor for establishing an electrical connection between a circuit including the cable and ground. A first plug is adapted to conduct the electric current between a contact provided to the source receptacle and the first terminal end, and a second plug is adapted to conduct the electric current between the second terminal end and a contact provided to the load receptacle. At least one of the first plug and the second plug is compatible with a single-prong receptacle.

Abstract: Methods of modulating the immune response using pharmaceutical compositions containing crystalline adjuvants are described. In various embodiments the crystalline adjuvants are selected from the group consisting of monosodium urate (MSU), xanthine, basic calcium phosphate (BCP), calcium pyrophosphate dihydrate (CPPD), hydroxyapatite, calcium oxalate, cholesterol, lipid liquid, other crystalline lipids, lithium heparin, talc, and starch.

Abstract: Antibodies that bind to a 40 kDa protein which is expressed on tumors, but is not expressed on normal adult hemopoietic cells are disclosed. Also disclosed are methods for production and the use of such antibodies.

Abstract: The invention provides compositions and methods for inducing MHC class I-restricted cytotoxic T lymphocyte responses in a mammalian host by immunization with non-replicating protein antigens. The compositions of the invention comprise a particulate-protein complex capable of inducing a class I-restricted CTL response to a protein antigen in a mammal, in which the particulate protein complex comprises a particulate component having an average diameter ranging in size from about 0.5 .mu.m to about 6 .mu.m, linked to a non-replicating protein antigen derived from a tumor cell or from pathogenic organism where CTL response is likely to play an important role in conferring protective immunity in a mammal, with the proviso that the particulate component is not a prokaryotic or eukaryotic cell or a micellar multimicellar, or liposome vesicle composed of detergents or lipids.

Abstract: This invention relates to a process for preparing 2-oxazolines which comprises cyclodehydrating a hydroxyalkylamide in the presence of a stannous salt of a carboxylic acid. The 2-oxazolines have a variety of uses such as pharmaceutical intermediates, pharmaceuticals and as stabilizers for resins.